Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities

February 28, 2011 4:34 pm | by EurekAlert | News | Comments

(American Society of Hematology) Results from a study published in Blood, the journal of the American Society of Hematology, reveal a close relationship between pulmonary arterial hypertension -- exceedingly high blood pressure in the arteries carrying blood from the heart to the lungs --...

OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference

February 28, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

BOTHELL, Wash., and VANCOUVER, British Columbia, Feb. 28, 2011 /- OncoGenex Pharmaceuticals, Inc. (Nasdaq: OGXI ) announced today that Scott Cormack, OncoGenex's president and chief executive officer, will take part in a panel discussion on novel cancer treatments at the upcoming RBC...

Fish oil fights weight loss due to chemotherapy

February 27, 2011 8:32 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) A new analysis has found that supplementing the diet with fish oil may prevent muscle and weight loss that commonly occurs in cancer patients who undergo chemotherapy. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study...

Advertisement

Radio-guided surgery a safe and simple way to remove potentially cancerous nodules in the lung

February 25, 2011 10:33 pm | by EurekAlert | News | Comments

(European Society for Medical Oncology) Using tiny spheres of radioactive liquid to guide surgeons as they remove potentially cancerous material in the lungs is safe and more effective than other techniques, Italian researchers report.

Erlotinib effective and with fewer side-effects after first-line treatment

February 25, 2011 10:33 pm | by EurekAlert | News | Comments

(European Society for Medical Oncology) The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show.

ERT to Present at the Citi 2011 Global Health Care Conference on March 2, 2011

February 25, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, Feb. 25, 2011 /- ERT (Nasdaq: ERES ), announced today that Dr. Joel Morganroth, the Company's Chairman and CEO, and Keith Schneck, the Company's Chief Financial Officer, are scheduled to present at the Citi 2011 Global Health Care Conference at 10:00 AM ET on March 2,...

Seniors in Florida Report Problems Obtaining Needed Home Medical Equipment and Services Under Controversial Medicare Bidding System

February 25, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., Feb. 25, 2011 /PRNewswire-USNewswire/ -- Medicare beneficiaries are reporting problems receiving required home medical equipment and services in the wake of the January 1, 2011 implementation of Medicare's controversial "competitive" bidding program in Miami and Orlando,...

Bone drug zoledronic acid may help prevent spread of early lung cancer

February 24, 2011 10:33 pm | by EurekAlert | News | Comments

(European Society for Medical Oncology) A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers have found.

Advertisement

Vertex sees positive data from Phase 3 CF study

February 23, 2011 9:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Vertex Pharmaceuticals Inc. of Cambridge today released results of a Phase 3 study of its VX-770 drug candidate for a specific type of cystic fibrosis (CF) that showed a relative mean improvement in lung function of about 17 percent over placebo.

European Multidisciplinary Conference in Thoracic Oncology -- press program

February 23, 2011 5:35 am | by EurekAlert | News | Comments

(European Society for Medical Oncology) The following studies will be presented in the Press Program of the second European Multidisciplinary Conference in Thoracic Oncology, a multipartner initiative for physicians of all medical disciplines dealing with lung cancer and other thoracic malignancies.

Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation

February 23, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., Feb. 23, 2011 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation and Vertex Pharmaceuticals announced today that VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis, showed promising results in a Phase 3 clinical...

Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call

February 23, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

RICHMOND, Va., Feb. 23, 2011 /- Insmed Incorporated (Nasdaq: INSM ), a biopharmaceutical company, announced today that it will host a conference call on Thursday, March 10th, 2011, at 8:30 AM EST, to discuss its financial results for the fourth quarter and year-end 2010.  Insmed...

Reportlinker Adds Global Artificial Organs Industry

February 23, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Artificial Organs Industry http://www.reportlinker.com/p092544/Global-Artificial-Organs-Industry.html This report analyzes the worldwide markets for Artificial...

Advertisement

Reportlinker Adds Global Prepackaged Medical Kits and Trays Industry

February 23, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Prepackaged Medical Kits and Trays Industry http://www.reportlinker.com/p090645/Global-Prepackaged-Medical-Kits-and-Trays-Industry.html This report analyzes the...

Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device

February 22, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

STEVENSVILLE, Md., Feb. 22, 2011 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Therapy (HFT™) products, has received 510(k) clearance from the Food and Drug Administration (FDA) for the Flowrest® homecare device.  The device also recently...

Masimo to Present at the Cowen and Company Health Care Conference

February 22, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Feb. 22, 2011 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Cowen and Company Health Care Conference at The Marriott Copley Place in Boston on Tuesday, March 8, 2011, at 8:45 a.m. E.T.  A live audiocast of the...

Vaccine made with synthetic gene protects against deadly pneumonia

February 21, 2011 8:35 pm | by EurekAlert | News | Comments

(Albert Einstein College of Medicine) Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine,...

Mater Children's Hospital in Australia Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities

February 21, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif. and BRISBANE, Australia, Feb. 21, 2011 /- Mater Children's Hospital and Masimo (Nasdaq: MASI ) today jointly announce the conversion of Mater Children's Hospital to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring...

Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call

February 18, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

CARY, N.C., Feb. 18, 2011 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) today announced that it will host a conference call at 8:30 AM ET on Thursday, March 3, 2011, to discuss its financial results for the quarter and twelve months ended December 31, 2010. Financial results are...

Two Knee Replacements May Be Better Than One

February 18, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 18, 2011 /PRNewswire-USNewswire/ -- Replacing both knees in one surgery, or simultaneous total knee replacement (TKR) was associated with significantly fewer prosthetic joint infections as well as other revision knee operations within one year after surgery, compared with...

NexBioâ??s DAS181 (Fludase®*) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis

February 17, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 17, 2011 /- NexBio, Inc. announced the presentation of "Treatment of Parainfluenza 3 Infection with DAS181 in a Patient after Allogeneic Stem Cell Transplantation" at the American Society for Blood and Bone Marrow Transplant meeting February 17-21 in Honolulu, Hawaii....

Dr. Jeffrey Freitag Appointed Chief Medical Officer of PharmaNet

February 17, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Feb. 17, 2011 /- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Jeffrey Freitag, M.D., Senior Vice President, PharmaNet Consulting,...

2 knee replacements may be better than 1

February 16, 2011 9:32 pm | by EurekAlert | News | Comments

(American Academy of Orthopaedic Surgeons) Replacing both knees in one surgery, or simultaneous total knee replacement was associated with significantly fewer prosthetic joint infections as well as other revision knee operations within one year after surgery, compared with total knee...

AirPal Receives Patent for Inflatable Patient Positioning Systems

February 16, 2011 7:31 am | by Bio-Medicine.Org | News | Comments

NORTH WALES, Pa., Feb. 16, 2011 /- AirPal, a medical device manufacturer headquartered in North Wales, Pennsylvania, has received notification of allowance from the U.S. Patent Office for its modular system of inflatable devices used to position patients for situations such as difficult...

Wireless Heart Implant Reduces Hospitalizations

February 15, 2011 7:34 pm | by Massachusetts Institute of Technology | News | Comments

A pressure-sensing implant helps heart-failure patients stay healthy.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading